Disclaimer: This article was published in 2021 and reflects the information available at that time.
  The approval of the Pfizer Comirnaty Orange Cap (5-11 years) COVID-19 vaccine to be administered by pharmacists from 10 January 2022 offers opportunities and challenges for pharmacists. PDL encourages pharmacists to prepare for this service now and consider the following to minimise risk. Preparation and administration key points  Comirnaty (Orange Cap) is a specifically formulated paediatric vaccine provisionally approved by TGA in the 5–11-year-old age range. Comirnaty (Orange Cap) is the only vaccine approved for this age group at time of this alert. …

Member only access

This content is available to PDL members only.
To continue reading please log in to the member portal or join PDL today.

Share this article

Related Practice Alerts

Professional Indemnity cover for pharmacy students
21 April 2026
NationalIncident managementRegulatory and compliancePractice support, tips and tools
Learn more
Communication matters
16 April 2026
NationalNSWLeadership and communicationIncident managementPractice support, tips and tools
Learn more
Professional Indemnity Insurance – what hospital pharmacists need to know
1 April 2026
National
Learn more